These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22540921)

  • 1. Punctate leucoderma after low-fluence 1,064-nm quality-switched neodymium-doped yttrium aluminum garnet laser therapy successfully managed using a 308-nm excimer laser.
    Kim HS; Jung HD; Kim HO; Lee JY; Park YM
    Dermatol Surg; 2012 May; 38(5):821-3. PubMed ID: 22540921
    [No Abstract]   [Full Text] [Related]  

  • 2. Punctate leucoderma after 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low-fluence therapy: is it melanocytopenic or melanopenic?
    Kim T; Cho SB; Oh SH
    Dermatol Surg; 2010 Nov; 36(11):1790-1. PubMed ID: 20961356
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy.
    Ryu HJ; Kim J
    J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chemical leukoderma using a 308-nm excimer laser.
    Ghazi E; Ragi J; Milgraum S
    Dermatol Surg; 2012 Aug; 38(8):1407-9. PubMed ID: 22681785
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma.
    Zhou X; Gold MH; Lu Z; Li Y
    Dermatol Surg; 2011 Jul; 37(7):962-70. PubMed ID: 21615824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
    Lee Y; Choi EH; Lee SW
    Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
    Brown AS; Hussain M; Goldberg DJ
    J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Draelos Z
    Dermatol Surg; 2011 Jan; 37(1):126-7. PubMed ID: 21214668
    [No Abstract]   [Full Text] [Related]  

  • 9. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy.
    Kim MJ; Kim JS; Cho SB
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):960-2. PubMed ID: 19207672
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling.
    Vachiramon V; Sahawatwong S; Sirithanabadeekul P
    Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the 308-nm excimer laser for postresurfacing leukoderma.
    Friedman PM; Geronemus RG
    Arch Dermatol; 2001 Jun; 137(6):824-5. PubMed ID: 11405786
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema ab igne successfully treated using 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low fluence.
    Cho S; Jung JY; Lee JH
    Dermatol Surg; 2011 Apr; 37(4):551-3. PubMed ID: 21481074
    [No Abstract]   [Full Text] [Related]  

  • 13. Formation of new melasma lesions in the periorbital area following high-fluence, 1064-nm, Q-switched Nd/YAG laser.
    Lee WJ; Kim YJ; Noh TK; Chang SE
    J Cosmet Laser Ther; 2013 Jun; 15(3):163-5. PubMed ID: 23656545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients.
    Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC
    J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
    Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
    Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary on Clinical and Histopathological Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
    Morton LM
    Dermatol Surg; 2016 Apr; 42(4):513-4. PubMed ID: 26949932
    [No Abstract]   [Full Text] [Related]  

  • 17. Spotted leucoderma after treatment of facial hyperpigmentation on hemodialysis patients employing 1064-nm Q-switched Nd:YAG laser.
    Hwang CY; Lin CS; Tseng ML; Liu HN
    J Cosmet Laser Ther; 2010 Feb; 12(1):47-50. PubMed ID: 19929290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial nevus depigmentosus getting remarkable repigmentation by treatment with a 308-nm excimer laser: A case report.
    Zeng Q; Shi Q; Huang J; Huang J; Tang Z; Xi C; Chen J
    Dermatol Ther; 2018 Sep; 31(5):e12662. PubMed ID: 30198202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of a novel dual--pulsed 1064 nm Q-switched Nd: YAG laser to treat Riehl's melanosis.
    Chung BY; Kim JE; Ko JY; Chang SE
    J Cosmet Laser Ther; 2014 Dec; 16(6):290-2. PubMed ID: 25046351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of infraorbital dark circles using a low-fluence Q-switched 1,064-nm laser.
    Xu TH; Yang ZH; Li YH; Chen JZ; Guo S; Wu Y; Liu W; Gao XH; He CD; Geng L; Xiao T; Chen HD
    Dermatol Surg; 2011 Jun; 37(6):797-803. PubMed ID: 21605241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.